From MarketBeat:

Sumitomo Mitsui Trust Holdings Inc. decreased its STERIS plc position by 2.8% to 0.24% of the stock, totaling 236,345 shares worth $51,859,000 by the end of last quarter. Other institutional investors grew their stake in STERIS, with 92.91% of the stock owned by hedge funds and other institutional investors.

Analysts set a new price target for STERIS, with various research reports rating the stock. Current consensus rating of “Moderate Buy” with a consensus price target of $240.60.

STERIS stock recently opened at $223.40.
STERIS last had quarterly earnings data on November 7th, reporting $2.03 EPS, missing the estimated $2.05 by $0.02.

The company also announced quarterly dividends with a payout ratio of 37.61%.

Company Profile: STERIS plc provides infection prevention products and services worldwide through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.

MarketBeat keeps track of top-rated research analysts and the stocks they recommend, identifying five stocks better than STERIS.



Read more: Sumitomo Mitsui Trust Holdings Inc. Trims Stock Holdings in STERIS plc (NYSE:STE)